Bottom line
LOGSX vs RYHIX: the short answer
LOGSX (Live Oak Health Sciences Fund) and RYHIX (Health Care Fund) are quite different portfolios: only about 39% of their top holdings (by weight) are shared.
But RYHIX is far broader, holding 135 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
LOGSX is cheaper at 1.04% vs 1.38% — a difference of $34 a year per $10,000 invested.
Over five years, LOGSX returned +8.1% a year vs +5.1% for RYHIX.
Updated Nov 19, 2026
LOGSX vs RYHIX side by side
| LOGSX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Oak Associates | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.04% | 1.38% |
| Annual cost per $10k | $104 | $138 |
| 10-yr cost on $10k (prospectus) | $1,271 | $1,709 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +19.6% | +14.4% |
| 5-yr return (annualized) | +8.1% | +5.1% |
| 10-yr return (annualized) | +7.3% | +7.9% |
| Best quarter | +13.4% | +18.7% |
| Worst quarter | −13.1% | −14.4% |
| Net assets (fund) | $56.1M | $19.4M |
| Number of holdings | 28 | 135 |
| Portfolio turnover | 24% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LOGSX | RYHIX | Difference |
|---|---|---|---|
| 2025 | +19.6% | +14.4% | +5.2% |
| 2024 | +0.2% | +0.6% | −0.4% |
| 2023 | +1.2% | +5.8% | −4.7% |
| 2022 | +3.7% | −11.6% | +15.3% |
| 2021 | +17.5% | +19.2% | −1.7% |
| 2020 | +6.0% | +18.9% | −13.0% |
| 2019 | +19.0% | +22.8% | −3.8% |
| 2018 | −4.0% | +1.6% | −5.5% |
| 2017 | +13.4% | +23.5% | −10.1% |
| 2016 | −0.4% | −9.4% | +9.0% |
Source: Fund prospectus bar charts
Holdings overlap
13 of LOGSX's top 25 holdings also appear in RYHIX's top 25.
| Holding | LOGSX | RYHIX |
|---|---|---|
| Cardinal Health Inc | 5.86% | 0.86% |
| Amgen Inc | 4.86% | 1.56% |
| Mckesson Corp | 4.53% | 1.05% |
| Regeneron Pharmaceuticals Inc | 4.43% | 0.90% |
| Bristol-myers Squibb Company | 4.02% | 1.22% |
| Johnson & Johnson | 3.77% | 2.88% |
| Gilead Sciences Inc | 3.50% | 1.39% |
| Cigna Group (the) | 3.46% | 0.94% |
| Vertex Pharmaceuticals Inc | 3.26% | 1.34% |
| Merck & Company Inc | 3.16% | 2.04% |
| Intuitive Surgical Inc | 2.99% | 1.31% |
| Novo Nordisk A/s | 2.51% | 0.83% |
| Eli Lilly & Company | 1.99% | 3.63% |
Source: SEC Form N-PORT
LOGSX top 10
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Exelixis Inc — 4.95%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between LOGSX and RYHIX?
Which is cheaper, LOGSX or RYHIX?
Should I own both LOGSX and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.